Maccura Biotechnology Co.Ltd (SHE:300463)

China flag China · Delayed Price · Currency is CNY
11.75
-0.14 (-1.18%)
At close: Feb 26, 2026
Market Cap7.10B -7.2%
Revenue (ttm)2.21B -19.0%
Net Income-117.46M
EPS-0.19
Shares Out604.67M
PE Ration/a
Forward PE29.38
Dividend0.10 (0.88%)
Ex-Dividend DateMay 28, 2025
Volume7,787,575
Average Volume21,025,341
Open11.89
Previous Close11.89
Day's Range11.72 - 11.89
52-Week Range10.90 - 15.40
Beta0.35
RSI48.54
Earnings DateApr 29, 2026

About SHE:300463

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such as digital PCR and extraction systems, and PCR kits; urinalysis analyzer systems and semi-automatic urine analyzers; and hemostasis solutions, including... [Read more]

Sector Healthcare
Founded 1994
Employees 3,106
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300463
Full Company Profile

Financial Performance

In 2024, SHE:300463's revenue was 2.55 billion, a decrease of -11.98% compared to the previous year's 2.90 billion. Earnings were 126.81 million, a decrease of -59.44%.

Financial Statements